HZSKBIO

BiotechnologySeries BHuzhou, Chinashenkebio.com

Latest round

Series B

Last raised

Jan 2023

Total raised

Undisclosed

Investors

6

About HZSKBIO

Based in Huzhou, China, and established in 2012, HZSKBIO is a biotechnology company that provides testing technology services and testing regent kits for biological medical drugs. It has two R&D centres in Huzhou, and Shanghai. The Huzhou R&D centre has a protein, and nucleic acid testing lab, cell lab, and microbiology lab, which is equipped with fluorescence quantification PCR equipment, laser scanners, protein Purification, and other lab equipment. HZSKBIO undertook more than 30 result transform programs and 6 province-level technology programs and served more than 500 biopharmaceutical companies. It also established a production base and received quality management system certification, ISO13485. In 2016, it launched rHCD testing reagent kits. In 2018, it launched mycoplasma DNA extraction and detection reagent kits, and human residual DNA pieces analysis and detection reagent kits. In 2019, it launched CAR gene copy number detection reagent kits. In 2020, it launched reverse transcriptase activity assay kits and kanamycin residue assay kits. HZSKBIO's products can be divided into pre-precess supported equipment systems, qPCR detection reagent kits, dPCR detection reagent kits, and ELISA detection reagent kits. The qPCR detection kits include host cell residual DNA and RNA detection reagent kits, virus detection reagent kits, reverse transcriptase activity detection reagent kits, and CAR copy number detection reagent kits. And the ELISA detection reagent kits include kanamycin residue detection reagent kits, host cell protein detection reagent kits, and nuclease residue detection reagent kits.

Who invested in HZSKBIO

6 investors across 1 round

See all investors in HZSKBIO

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jan 19, 2023

    Amount

    Undisclosed

    Investors

    Locked

Questions about HZSKBIO

Who invested in HZSKBIO?

HZSKBIO has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has HZSKBIO raised?

HZSKBIO has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did HZSKBIO last raise money?

HZSKBIO's most recent round on record is a Series B, in Jan 2023.

What does HZSKBIO do?

Based in Huzhou, China, and established in 2012, HZSKBIO is a biotechnology company that provides testing technology services and testing regent kits for biological medical drugs.

Where is HZSKBIO headquartered?

HZSKBIO is headquartered in Huzhou, China.

Which VCs invest in companies like HZSKBIO?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at HZSKBIO's stage. Their profiles are linked below.

Raising like HZSKBIO? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.